This bill seeks to expand the role of pharmacists in the treatment of opioid use disorder by granting them the authority to initiate, prescribe, administer, and dispense specific medications for this purpose. It amends Minnesota Statutes 2024, section 151.01, subdivision 27, to officially recognize these activities as part of the practice of pharmacy. Additionally, the definition of "practitioner" in section 151.01, subdivision 23, is updated to include pharmacists who are authorized to prescribe certain medications, while removing references to self-administered hormonal contraceptives and nicotine replacement medications. The bill also establishes specific training and documentation requirements for pharmacists engaging in these activities and mandates that they counsel patients on the proper use of prescribed medications.

Moreover, the legislation revises the grounds for disciplinary action against pharmacists and pharmacy interns, maintaining a comprehensive list of prohibited conduct to ensure adherence to ethical and professional standards. It introduces a new violation for conduct that does not conform to accepted healthcare standards and clarifies prescription requirements for controlled substances. Overall, the bill aims to enhance the management of opioid use disorder through the expanded responsibilities of pharmacists while reinforcing compliance with licensing and regulatory requirements.

Statutes affected:
Introduction: 151.01, 151.071, 151.37, 152.11, 152.12